Justin Tyler Gibson

5PUBLICATIONS
9CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 02, 2021
Diet-Induced Obesity Impairs Outcomes and Induces Multi-Factorial Deficiencies in Effector T Cell Responses Following Anti-CTLA-4 Combinatorial Immunotherapy in Renal Tumor-Bearing Mice.

William J Turbitt, Shannon K Boi, Justin T Gibson

|Jan 11, 2021
Obesity diminishes response to PD-1-based immunotherapies in renal cancer.

Shannon K Boi, Rachael M Orlandella, Justin Tyler Gibson

|Oct 10, 2020
The Antidiabetic Agent Acarbose Improves Anti-PD-1 and Rapamycin Efficacy in Preclinical Renal Cancer.

Rachael M Orlandella, William J Turbitt, Justin T Gibson

|May 30, 2020
Obesity induces limited changes to systemic and local immune profiles in treatment-naive human clear cell renal cell carcinoma.

Justin T Gibson, Katlyn E Norris, Gal Wald

|Jul 20, 2019
Mutations in the S-Adenosylmethionine Synthetase Genes SAM1 and SAM2 Differentially Affect Genome Stability in Saccharomyces cerevisiae.

Kellyn M Hoffert, Kathryn S P Higginbotham, Justin T Gibson

Pageof 1

Frequent Collaborators

3 joint publications

Lyse A Norian

2 joint publications

Rachael M Orlandella

1 joint publications

Kellyn M Hoffert

1 joint publications

Erin D Strome